Continuum Advisory’s Colgate-Palmolive CL Stock Holding History
Bought
Maintained
Sold
Other funds holding CL
BC
Continuum Advisory's CL Position: Q2 2025 in Review
Continuum Advisory sold out of Colgate-Palmolive (CL) in Q2 2025, closing a stake of 1,171 shares — an estimated $110K sold.
Continuum Advisory first reported a position in CL in Q1 2024 and held it in 5 quarters. The position peaked at $110K in Q1 2025. 1,913 funds tracked by Wall St. Rank hold CL as of Q2 2025.
- Continuum Advisory reported no remaining Colgate-Palmolive position as of Q2 2025 after selling out during the quarter.
- Continuum Advisory sold 1,171 Colgate-Palmolive shares in Q2 2025, an estimated $110K.
- Continuum Advisory first reported a position in Colgate-Palmolive in Q1 2024 and held it in 5 quarters.
- Continuum Advisory's Colgate-Palmolive position peaked at $110K in Q1 2025.
- 1,913 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2025.
Based on Continuum Advisory's 13F filing for Q2 2025, filed 13 Aug 2025.